Peroxiredoxin-4, a Marker of Systemic Oxidative Stress, is Associated with Incident Heart Failure
European Journal of Heart Failure · 2025
DOI: 10.1002/ejhf.3653 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Heart Failure, 2025. Verfasst von Navin Suthahar und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Erasmus MC, Cardiovascular Institute, Thorax Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Oxidative Stress, Heart Failure, Peroxiredoxins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Netherlands Heart Foundation (Hartstichting), Nierstichting (Dutch Kidney Foundation), Dutch Heart Foundation.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
Oxidative stress is known to be involved in the pathophysiology of heart failure (HF). To assess oxidative stress, direct quantification of reactive oxygen species would be ideal but this is not feasible due to their short half-lives. Antioxidant enzymes such as peroxiredoxins, produced as a direct response to oxidative stress, mirror the process and can be more easily quantified. The aim of this study was to examine whether circulating peroxiredoxin-4 (Prx4), a marker of systemic oxidative stress, associates with incident HF and its subtypes. Methods and results We included a total of 8199 individuals from the Prevention of REnal and Vascular End-stage Disease (PREVEND) community-based cohort (mean age: 49.8 years; 50.1% women). During a median follow-up of 12.6 years, 349 (4.3%) HF events occurred of which 118 (33.8%) had HF with preserved ejection fraction. In a Cox proportional hazards model adjusting for age, sex, smoking, diabetes, hypertension, obesity, total and high-density lipoprotein cholesterol, cholesterol-lowering medication and renal disease, Prx4 was significantly associated with incident HF (hazard ratio [HR] per 1 standard deviation increase in log-Prx4: 1.22; 95% confidence interval [CI] 1.09–1.36; p < 0.001). Among HF subtypes, Prx4 remained associated with incident HF with preserved (HR 1.27; 95% CI 1.05–1.53) as well as reduced ejection fraction (HR 1.19; 95% CI 1.04–1.37), with no significant difference between the subtypes (p = 0.64).
Conclusion
Circulating Prx4 associates with the risk of developing HF, both with preserved and reduced ejection fraction. Future studies should examine whether Prx4 can serve as a real-time marker of oxidative stress status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Erasmus MC, Cardiovascular Institute, Thorax Center, Rotterdam, The Netherlands.
- Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University Medical Center, Maastricht, The Netherlands.
- Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
- Division of Nephrology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
- Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Amsterdam, The Netherlands.
- Department of Physiology, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
ORCID-Profile: Navin Suthahar
Förderung
- Netherlands Heart Foundation (Hartstichting)
- Nierstichting (Dutch Kidney Foundation)
- Dutch Heart Foundation
- Netherlands Organization for Scientific Research
- European Research Council
- Hartstichting
- H2020 European Research Council
Zitieren
APA
Suthahar, N., Mourmans, S. G. J., Achten, A., Aboumsallem, J. P., Meijers, W. C., Bomer, N., Kardys, I., Gansevoort, R. T., Bakker, S. J. L., Weerts, J., Eringa, E. C., Damman, K., van Empel, V., & de Boer, R. A. (2025). Peroxiredoxin-4, a Marker of Systemic Oxidative Stress, is Associated with Incident Heart Failure. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.3653
Vancouver
Suthahar N, Mourmans SGJ, Achten A, Aboumsallem JP, Meijers WC, Bomer N, et al. Peroxiredoxin-4, a Marker of Systemic Oxidative Stress, is Associated with Incident Heart Failure. European Journal of Heart Failure. 2025. doi:10.1002/ejhf.3653
BibTeX
@article{Suthahar2025,
author = {Suthahar, Navin and Mourmans, Sanne G J and Achten, Anouk and Aboumsallem, Joseph Pierre and Meijers, Wouter C and Bomer, Nils and Kardys, Isabella and Gansevoort, Ron T and Bakker, Stephan J L and Weerts, Jerremy and Eringa, Etto C and Damman, Kevin and van Empel, Vanessa and de Boer, Rudolf A},
title = {Peroxiredoxin-4, a Marker of Systemic Oxidative Stress, is Associated with Incident Heart Failure},
journal = {European Journal of Heart Failure},
year = {2025},
doi = {10.1002/ejhf.3653}
}
EUVIMED